Last: | $1.455 |
---|---|
Change Percent: | -2.35% |
Open: | $1.51 |
Close: | $1.49 |
High: | $1.53 |
Low: | $1.44 |
Volume: | 1,922,202 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.455 | $1.51 | $1.49 | $1.53 | $1.44 | 1,922,202 | 07-22-2024 |
$1.49 | $1.51 | $1.49 | $1.55 | $1.46 | 4,107,719 | 07-19-2024 |
$1.52 | $1.53 | $1.52 | $1.56 | $1.46 | 10,413,143 | 07-18-2024 |
$1.42 | $1.43 | $1.42 | $1.44 | $1.38 | 3,218,157 | 07-17-2024 |
$1.44 | $1.45 | $1.44 | $1.47 | $1.42 | 6,873,209 | 07-16-2024 |
$1.43 | $1.39 | $1.43 | $1.47 | $1.39 | 5,852,355 | 07-15-2024 |
$1.38 | $1.37 | $1.38 | $1.4 | $1.35 | 1,371,541 | 07-12-2024 |
$1.37 | $1.34 | $1.37 | $1.42 | $1.32 | 6,022,601 | 07-11-2024 |
$1.32 | $1.3 | $1.32 | $1.32 | $1.29 | 1,253,558 | 07-10-2024 |
$1.29 | $1.3 | $1.29 | $1.3 | $1.27 | 2,162,866 | 07-09-2024 |
$1.29 | $1.27 | $1.29 | $1.31 | $1.27 | 1,628,877 | 07-08-2024 |
$1.26 | $1.21 | $1.26 | $1.26 | $1.19 | 1,872,750 | 07-05-2024 |
$1.215 | $1.21 | $1.215 | $1.235 | $1.2 | 833,448 | 07-04-2024 |
$1.215 | $1.21 | $1.215 | $1.235 | $1.2 | 833,448 | 07-03-2024 |
$1.21 | $1.23 | $1.21 | $1.2395 | $1.21 | 1,385,562 | 07-02-2024 |
$1.23 | $1.23 | $1.23 | $1.255 | $1.22 | 1,892,524 | 07-01-2024 |
$1.25 | $1.27 | $1.25 | $1.29 | $1.21 | 9,359,477 | 06-28-2024 |
$1.26 | $1.27 | $1.26 | $1.28 | $1.23 | 1,895,581 | 06-27-2024 |
$1.28 | $1.27 | $1.28 | $1.29 | $1.25 | 1,875,403 | 06-26-2024 |
$1.29 | $1.32 | $1.29 | $1.34 | $1.29 | 2,267,914 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...